Castration-resistant prostate cancer (CRPC) is fatal and there is currently no effective clinical treatment. The antibiotic doxycycline has shown anti-cancer effect in several kinds of solid tumors including prostate cancer. In this study, a combination of doxycycline and doxorubicin was used to investigate the synergistic effect on CRPC cells. MTT assay was employed to determine the viability of cells in two-dimensional (2D) cultures. Apoptosis was determined by Annexin V/propidium iodide (PI) double staining assay. Cell cycle was analyzed by PI staining, and reverse transcription-PCR (RT-PCR) was used to determine the expressions of apoptosis-related genes at mRNA level. Western blot analysis was used to analyze the expressions of Bcl-2, Bax, and Poly (ADP-ribose) polymerase proteins. Cytotoxicity assay and morphological observation of PC3 cells in three-dimensional (3D) cultures were used to determine the effect of combination treatment. Results showed that doxycycline combined with doxorubicin significantly inhibited PC3 cells in both 2D and 3D cultures, enhanced apoptosis, and increased the accumulation of cells in G2/M phase. RT-PCR showed downregulation of Bcl-2 and up-regulation of Bax mRNA after combination treatment. Meanwhile, western blot analysis showed that combination treatment resulted in down-regulation of Bcl-2 protein and up-regulation of Bax protein, and that PARP cleavage was obviously exhibited after combination treatment. Confocal imaging analysis indicated that doxorubicin penetrated deeply into the core of spheroids when combined with doxycycline. These data indicated that doxycycline in combination with doxorubicin had a synergistic effect on PC3 cells and may provide a potential novel strategy for the treatment of CRPC.
Introduction
Prostate cancer is one of the most common cancers among men in Western countries and remains the second leading cause of cancerrelated death in men in the USA [1, 2] . Deprivation of androgen is one of the effective strategies to treat prostate cancer which is androgen dependent. However, in most cases prostate cancer cells will progress to castration-resistant prostate cancer (CRPC) cells after long-term androgen ablation. At present, the median survival is 15-36 months due to the lack of effective clinical treatments for CRPC [3] .
As CRPC is resistant to androgen ablation, chemotherapy is one of the common clinical strategies. Doxorubicin (DOX) has been widely used to treat various kinds of solid tumors including prostate cancer. Its anti-tumor effect is mainly based on its actions of damaging DNA and causing apoptosis by cell cycle arrest in the G2/M phase [4] . However, its adverse effects including cardio-toxicity limited its application [5, 6] . Thus, as a second line therapy to CRPC, DOX is often combined with other anti-cancer drugs in clinic [7, 8] .
Doxycycline (DC), a member of the tetracycline family, has been used as an antibiotic for many years. In addition to its antibiotic properties caused by disrupting bacterial protein synthesis through inhibiting the binding of aminoacyl t-RNA to 30 S ribosomes, DC was also reported to have pro-apoptotic activity and metastasis inhibition in some kinds of cancer cells [9] [10] [11] [12] [13] [14] [15] . Moreover, recent studies also revealed that DC possesses anti-cancer activity by disturbing mitochondrial function [16, 17] . DC is shown to inhibit the growth of several types of cancer cells including prostate cancer cells through active oxidative phosphorylation (OXPHOS) and significant reduction of the oxygen consumption in cancer cells [18] . Prostate cancer cells are highly sensitive to OXPHOS inhibitors, indicating that DC may be used as adjuvant for the treatment of this type of cancer [19] .
In addition to its anti-cancer property, DC has also been reported to combine with other types of anti-cancer drugs to generate a synergistic therapeutic effect. For example, DC can enhance the cytotoxic and pro-apoptotic activity of other anti-cancer drugs such as cisplatin and oxaliplatin against some types of cancer cells including ovarian and colorectal cancer cells [20, 21] .
In the present study, we explored whether DC can be used as a synergistic drug to enhance the cytotoxic and pro-apoptotic effects of DOX against PC3 prostate cancer cells. DC combined with DOX was used to investigate whether it could further reduce cell viability and increase apoptosis. Moreover, the underlying mechanisms of apoptosis induced by the combination treatment were also investigated. In addition to conventional two-dimensional (2D) cultures, we also introduced a threedimensional (3D) culture assay to investigate the effect of combination treatment on the spheroids formed by PC3 cells. 3D culture can provide more information about cell interactions and cell signaling, because it uses a microenvironment similar to the conditions in vivo [22] [23] [24] .
Materials and Methods

Cell line and reagents
The human normal hepatocytes cell line LO2, the human CRPC cell lines PC3, DU145 and non-CRPC cell line LNCaP were purchased from American Type Culture Collection (ATCC, Manassas, USA). LO2 cells were cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin. PC3, DU145 and LNCaP cells were cultured in RPMI 1640 medium supplemented with 10% FBS and 1% penicillin/streptomycin. All cell lines were cultured at 37°C in a 5% CO 2 humidified atmosphere.
Doxycycline hydrochloride was purchased from Sangon Biotech (Shanghai, China) and dissolved in distilled water. Doxorubicin hydrochloride was purchased from Hisun Pharmaceutical (Taizhou, China), dissolved in dimethyl sulphoxide (DMSO) and then diluted with culture medium before use. The final concentration of DMSO was less than 0.1% (v/v). Matrigel was purchased from BD Biosciences (Franklin Lakes, USA). RPMI 1640 medium was purchased from Solarbio (Beijing, China), and FBS was purchased from PAN-biotech (Aidenbach, Germany). Anti-Bcl-2 and anti-Bax antibodies were purchased from Beyotime (Beijing, China), and anti-PARP antibody was purchased from Cell Signaling Technology (Beverley, USA). 
Cell proliferation assay in 2D cultures
Cytotoxic assay of spheroids in 3D cultures
The cytotoxic effect on spheroids in 3D cultures was determined using an Alamar blue assay. PC3 cells were cultured on Matrigel using an on-top assay at a density of 2 × 10 3 cells/well. Spheroids formed by PC3 cells were cultured for 6 days before addition of DC alone (1.25 μM) or DOX alone (80 nM) or the combination of DC (1.25 μM) and DOX (80 nM). Medium supplemented with 10% Alamar blue was then added to the plates after 6 days of drug treatment. Spheroids without drug treatment were used as controls. The fluorescence of samples was measured at 560 nm of excitation and 590 nm of emission. 
Apoptosis analysis
RT-PCR
Total mRNA was extracted and converted to cDNA by RT-PCR. The amplification of PCR was carried out as follows: 95°C for 10 min, 35 cycles each of 95°C for 30 s, 56°C for 30 s, 72°C for 15 s, and then a final cycle of 10 min for 72°C. GAPDH was used to normalize the expression levels of genes. Cells without drug treatment were used as controls. The primers used were as follows Bcl-2: 5′-ATGACTGAGTACCTGAACCGGC-3′ and 5′-GAGA CAGCCAGGAGAAATCAAAC-3′;
Bax: 5′-CCTTTTGCTTCAGGGTTTCAT-3′ and 5′-CATCCTC TGCAGCTCCATGTTA-3′; and GAPDH: 5′-GTCTCCTCTGACTTCAACAGCG-3′ and 5′-ACC ACCCTGTTGCTGTAGCCAA-3′.
Western blot analysis
Cell lysates were centrifuged at 15,000 g for 30 min at 4°C. The extracted proteins were separated by 10% SDS-PAGE and electro-transferred onto polyvinylidene difluoride membranes. The membranes were blocked with 5% non-fat milk for 2 h and then incubated with primary antibody overnight at 4°C. After incubation, the membranes were washed with PBST and incubated with HRP-cojugated secondary antibody for 2 h at room temperature. β-Actin was used to normalize the expression levels of proteins. The protein bands were detected using enhanced chemiluminescence (ECL) reagent and visualized using a gel imaging system.
Confocal microscopy
PC3 cells (2 × 10 3 cells/well) were cultured on Matrigel using an on-top assay for 6 days. The spheroids formed by PC3 cells were treated with DOX alone (80 nM) or the combination of DC (1.25 μM) and DOX (80 nM) for another 6 days. Spheroids without drug treatment were used as controls. After treatment, the spheroids were washed with PBS three times and fixed with 4% paraformaldehyde for 10 min. The nuclei were stained with Hoechst 33342 for 10 min. Images were obtained and analyzed by laser scanning confocal microscopy and the spheroids were imaged with the z-stack at 3-μm intervals.
Statistical analysis
All experiments were repeated independently at least for three times. Data were shown as the mean ± standard deviation (SD). Student's t-test was used to determine the significance of data and P-value less than 0.05 was considered significantly different. The combination index (CI) of DC and DOX was calculated using CompuSyn software, which is based on the Chou-Talalay median effect method [25] . The CI value represents a synergistic (CI < 1), additive (CI = 1), or antagonist (CI > 1) effect.
Results
Combination treatment showed synergistic enhancement of cytotoxicity against CRPC and non-CRPC cells in 2D cultures PC3, DU145, and LNCaP cells were treated with different concentrations of DC alone (0.625 to 10 μM) or DOX alone (40 to 640 nM) for 72 h. As shown in Supplementary Figs. S1 and S2, the inhibition activity was increased in a concentration-dependent manner with single-drug treatment. And combination treatment with DC (1.25 μM) and DOX (40 to 320 nM) was used to investigate its effectiveness against PC3, DU145, and LNCaP cells. As shown in Fig. 1A -C, combination treatment showed enhanced inhibition activity against PC3, DU145, and LNCaP cells, compared with DC or DOX alone. Data in Table 1 showed that combination treatment with DC and DOX had synergistic effects on CRPC and non-CRPC cells. Meanwhile, MTT assay was also used to detect the effect of combination treatment on human normal hepatocytes LO2 cells. As shown in Fig. 1D , the combination of DC (1.25 μM) and DOX (80 nM) resulted in the lowest inhibition rate in the LO2 cells, compared with that in the PC3, DU145, and LNCaP cells, respectively, indicating that the combination treatment of DC and DOX had low cytotoxicity to normal cells at the concentrations of drugs used in the study.
Combination treatment enhanced the apoptosis of PC3 cells
Annexin V/PI double staining was used to investigate PC3 cell apoptosis induced by combination treatment with DC and DOX. As shown in Fig. 2A ,B, combination treatment dramatically increased the number of apoptotic cells compared with single-drug treatment. Statistical analysis using Student's t-test showed that the percentage of apoptotic cells caused by the combination of the two drugs was 23.35% ± 0.15%, significantly higher than that caused by DC alone (6.83% ± 0.91%, P < 0.01) or DOX alone (11.81% ± 0.53%, P < 0.05).
Combination treatment resulted in increased number of PC3 cells in the G2/M phase
We next investigated whether combination treatment with DC and DOX could induce cell cycle arrest of PC3 cells using PI staining and flow cytometry. As shown in Fig. 2C , an increased fraction of cells in the G2/M phase (56.85% ± 7.30%) was observed after combination treatment compared with control (6.47% ± 0.46%, P < 0.01), single-DC (9.16% ± 0.53%, P < 0.01) and single-DOX group (36.02% ± 4.25%, P < 0.05). These results indicated that combination treatment significantly increased the number of PC3 cells arrested in the G2/M phase of cell cycle, compared with single-drug treatment.
Combination treatment regulated the expressions of apoptosis-related genes at mRNA level Next, we investigated the expressions of apoptosis-related genes using RT-PCR. As shown in Fig. 3 , the mRNA expression levels of Bcl-2 and Bax genes were quantitatively measured by Image J software. The results showed that the combination of DC and DOX significantly decreased the expression of Bcl-2 mRNA (45.2% ± 1.6%), compared with that in the single-DC (87.2% ± 3.3%, P < 0.01) and single-DOX (76.1% ± 2.1%, P < 0.01) groups, respectively. Meanwhile, the expression level of Bax mRNA (180.2% ± 2.8%) was significantly increased in the combination group, compared with that in the single-DC (127.5% ± 3.3%, P < 0.01) and single-DOX (154.0% ± 2.6%, P < 0.01) groups, respectively, indicating that the combination treatment of DC and DOX synergistically regulated the expression of apoptosis-related genes at mRNA level.
Combination treatment regulated the expressions of Bcl-2, Bax, and PARP proteins in PC3 cells
To further elucidate the mechanism underlying the effect of combination treatment on PC3 cells, western blot analysis was used to determine the expressions of Bcl-2, Bax, and PARP proteins after combination treatment. The results were analyzed by Image J software. As shown in Fig. 4A -C, combination treatment significantly downregulated the expression of Bcl-2 protein (70.7% ± 3.3%) and upregulated that of Bax protein (135.7% ± 3.7%), compared with the results in the single-DC (84.0% ± 3.2%, P < 0.05 and 115.7% ± 2.9%, P < 0.05, respectively) and single-DOX group (81.7% ± 2.6%, P < 0.05 and 111.0% ± 1.4%, P < 0.01, respectively). Meanwhile, Fig. 4D showed that PARP cleavage was also obviously enhanced in the combination treatment group (433.6% ± 7.6%), compared with that in the single-DC (206.6% ± 7.9%, P < 0.05) and single-DOX (201.5% ± 2.5%, P < 0.01) groups, respectively, suggesting that combination treatment significantly induced the apoptosis of the PC3 cells.
Combination treatment was effective on spheroids in 3D cell cultures
As shown in Fig. 5 , in 3D cell cultures, DOX alone had no effect on the morphology, and only slight cytotoxic activity against spheroids (4.33% ± 0.56%, P < 0.01) was observed after treatment with DOX alone. However, DC alone made the spheroids disassociate into loose clusters of cells and showed higher cytotoxicity against spheroids (17.13% ± 4.06%, P < 0.05). Moreover, compared with DOX alone or DC alone, the combination treatment showed the most significant effect on disassociation of the spheroids. Furthermore, cytotoxic activity was enhanced when the spheroids were subject to combination treatment (30.67% ± 4.16%). These results indicated that combination treatment had greater cytotoxic activity and was more effective in inducing disassociation of the spheroids.
Confocal microscopy was used to further investigate the mechanism of combination treatment on the spheroids. As shown in Fig. 6 , DOX could penetrate deeply into the core of spheroids after combination treatment, compared with that observed in single doxorubicin group.
Discussion
In this study, we demonstrated that DC can synergize with DOX to inhibit the growth of CRPC and non-CRPC cells. In the clinic, almost all castration-dependent patients will invariably develop into castrationresistant phenotype, and new strategies on the CRPC treatment remain in urgent needs to improve the outcome of CRPC therapy in the clinic. Thus, as an exploration on the CRPC therapy, PC3 cells were used as a CRPC model in our study for the purpose of investigating the mechanism of combination treatment of DC and DOX in CRPC cells.
Apoptosis assay and cell cycle distribution were used to explore the mechanism of combined treatment on the PC3 cells. Our results showed that combination treatment with DC and DOX enhanced the apoptosis of the PC3 cells, and increased fraction of cells in the G2/M phase was also observed after combination treatment, indicating that To investigate the mechanism of apoptosis caused by combination treatment, the expressions of apoptosis-related genes were detected. Dysfunction in the regulation of apoptosis has important function in reducing the sensitivity of cancer cells. And the Bcl-2 family plays key roles in regulating apoptosis of cancer cells [26] [27] [28] [29] . Moreover, overexpression of Bcl-2 family members has been reported as an important factor in the regulation of CRPC survival and elevation of the threshold of apoptosis, thus reducing the sensitivity of CRPC to chemotherapy [30, 31] . The changes in the mRNA and protein expressions of Bcl-2 and Bax after combination treatment demonstrated that combined treatment of DC with DOX induced apoptosis of PC3 cells by regulating the expressions of Bcl-2 and Bax. On the other hand, PARP has important function in the process of cell cycle regulation, DNA repair, and apoptosis. As a substrate of caspase-3, its cleavage was considered as an important event in the apoptosis of cells [32, 33] . Compared with single-drug treatment, the cleavage of PARP was obviously increased after combination treatment of DC and DOX, showing that combination treatment was more effective to induce apoptosis of PC3 cells. Based on these results, we propose that combination of DC and DOX may induce the apoptosis of PC3 cells through regulating the expressions of Bcl-2, Bax, and PARP proteins.
The spheroids are constituted by organized extracellular matrix such as fibronectin, laminin, and collagen. And the spheroids formed in 3D cultures possess characteristics of tumor more similar to in vivo. As a model to test the effectiveness of chemotherapy, 3D culture assay was used to investigate the efficacy of drug delivery system and distribution of drug in the spheroids [34, 35] . Here, 3D cultures were used to further explore the efficacy and underlying mechanism of combination treatment on the PC3 cells cultured in 3D environment. In 3D cultures, low-dose DOX alone had no effect on the morphology of spheroids, and was only slightly effective in inducing cytotoxic effects after single-DOX treatment. The reason for the insensitivity of spheroids to DOX alone may be that cancer cells cultured in the 3D environment are more resistant to various anti-cancer drugs [36] . However, obvious disassociation of the spheroids and enhanced cytotoxic activity were observed in the single-DC group, compared with that of in single-DOX group, indicating that in addition to its cytotoxic effectiveness, DC alone could disrupt the organization of spheroids. To explore the relationship between enhanced cytotoxic activity and disassociation of the spheroids observed after combination treatment, confocal microscopy was used to detect the distribution of DOX in the spheroids. The confocal images showed that the DOX penetrated deeply into the core of the spheroids when combined with DC. Taken together, our results showed that the effectiveness of combination treatment on the spheroids included not only the cytotoxicity that DC induced, but also the enhanced cytotoxic effect of DOX via disrupting the organization of spheroids by DC. These results revealed the underlying mechanism of enhanced effectiveness of combination treatment on the spheroids to a certain extent, and further research is required to investigate the efficacy of combined treatment of DC with DOX on the CRPC cells in vivo.
In summary, we have revealed that DC enhances the effectiveness of DOX against CRPC cells both in 2D and 3D cultures, and the combined treatment of DC and DOX may provide a new potential therapeutic strategy for future clinical treatment.
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